http://www.alexion.com
Alexion Pharmaceuticals, Inc. Company Intro
Alexion is a global biopharmaceutical company focused on developing life-changing therapies for people living with rare disorders.
Industry
Healthcare
Alexion Pharmaceuticals, Inc. Headquaters
121 Seaport Boulevard
Boston,02210
United States
Alexion Pharmaceuticals, Inc. Share price
19 Jan 2021 01:05 GMT
$156.50
-0.15 (-0.1 %)
Alexion Pharmaceuticals, Inc. Market cap
$34.274 B
WMC RANKING
2021
Alexion Pharmaceuticals, Inc. # 2
BiotechnologyLatest Alexion Pharmaceuticals, Inc. News
18 Jan 2021
Rare Disease Drug Market Study by Verified Market Research ...
Hoffmann-La Roche Ltd. • Celgene Corporation • Bristol-Myers Squibb Company • Shire plc • Pfizer • Sanofi S.A. • Bayer • Alexion Pharmaceuticals
18 Jan 2021
Rare Disease Drug Market Study by Verified Market Research ...
Hoffmann-La Roche Ltd. • Celgene Corporation • Bristol-Myers Squibb Company • Shire plc • Pfizer • Sanofi S.A. • Bayer • Alexion Pharmaceuticals
18 Jan 2021
Rare Disease Drug Market Study by Verified Market Research ...
Hoffmann-La Roche Ltd. • Celgene Corporation • Bristol-Myers Squibb Company • Shire plc • Pfizer • Sanofi S.A. • Bayer • Alexion Pharmaceuticals
WMC Market Score
WMC Market to Revenue Score
Alexion Pharmaceuticals, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Alexion Pharmaceuticals, Inc. | USD | $5,862,400 | $2,588,400 | $956,600 | $342,740B | 2 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,243,500 | $5,152,600 | $3,156,000 | $552,660B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $5,991,128 | $2,596,854 | $2,690,691 | $586,520B | 3 |
| ALK-Abello A/S | USD | $3,383,000 | $1,831,000 | $43,000 | $273,380B | 4 |
| Incyte Corporation | USD | $2,229,409 | $1,622,822 | $446,906 | $198,320B | 5 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Alexion Pharmaceuticals, Inc. Social Followers vs Top 4 Industry Competitors
Alexion Pharmaceuticals, Inc. Post vs Top 4 Industry Competitors
Alexion Pharmaceuticals, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Alexion Pharmaceuticals, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Alexion Pharmaceuticals, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Alexion Pharmaceuticals, Inc. | 63.42 | 16.18 | 100 | 60 | 0 | 0 | 90.52 |
| Regeneron Pharmaceuticals, Inc. | 100 | 66.03 | 28.72 | 100 | 0 | 0 | 100 |
| Vertex Pharmaceuticals Incorporated | 64.81 | 100 | 8.81 | 86 | 0 | 0 | 99.94 |
| ALK-Abello A/S | 36.60 | 0 | 0 | 0 | 0 | 0 | 0 |
| Incyte Corporation | 24.12 | 14.24 | 10.48 | 2 | 0 | 0 | 13.94 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
